Inhalerx Ltd (IRX) — Strategic Asset Allocation Index
Inhalerx Ltd (IRX) has a Strategic Asset Allocation Index of 0.0% as of December 2022. Strategic assets (PP&E of AU$0.00 plus long-term investments of AU$-) total AU$0.00, measured against net assets of AU$1.93 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Inhalerx Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Inhalerx Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2022. As of December 2022, the index stands at 0.0%, representing strategic assets of AU$0.00 against net assets of AU$1.93 Million AUD. Explore IRX cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Inhalerx Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Inhalerx Ltd from 2016 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see IRX stock market capitalisation.
| Year | SAAI | Strategic Assets (AUD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | AU$0.00 | AU$0.00 | AU$- | AU$1.90 Million | ▼ -0.4 pp |
| 2021 | 0.4% | AU$9.71K | AU$9.71K | AU$- | AU$2.68 Million | ▲ +0.4 pp |
| 2019 | 0.0% | AU$0.00 | AU$0.00 | AU$- | AU$340.08K | ▼ -3.6 pp |
| 2018 | 3.6% | AU$96.11K | AU$96.11K | AU$- | AU$2.68 Million | ▲ +2.4 pp |
| 2017 | 1.2% | AU$54.43K | AU$54.43K | AU$- | AU$4.51 Million | ▲ +0.8 pp |
| 2016 | 0.4% | AU$27.00K | AU$27.00K | AU$- | AU$7.33 Million | — |